These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28639199)

  • 1. Treatment of Pancreatic Cancer by Aptamer Conjugated C/EBPα-saRNA.
    Yoon S; Rossi JJ
    Adv Exp Med Biol; 2017; 983():173-188. PubMed ID: 28639199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo.
    Yoon S; Huang KW; Reebye V; Mintz P; Tien YW; Lai HS; Sætrom P; Reccia I; Swiderski P; Armstrong B; Jozwiak A; Spalding D; Jiao L; Habib N; Rossi JJ
    Mol Ther; 2016 Jun; 24(6):1106-1116. PubMed ID: 26983359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC.
    Yoon S; Huang KW; Andrikakou P; Vasconcelos D; Swiderski P; Reebye V; Sodergren M; Habib N; Rossi JJ
    Mol Ther Nucleic Acids; 2019 Dec; 18():142-154. PubMed ID: 31546149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of CEBPA-saRNA for the treatment of pancreatic ductal adenocarcinoma by transferrin receptor aptamer decorated tetrahedral framework nucleic acid.
    Wang L; Yao Q; Guo X; Wang B; Si J; Wang X; Jing S; Yan M; Shi Y; Song G; Shen X; Guan J; Zhao Y; Zhu C
    J Nanobiotechnology; 2024 Jul; 22(1):392. PubMed ID: 38965606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo.
    Reebye V; Sætrom P; Mintz PJ; Huang KW; Swiderski P; Peng L; Liu C; Liu X; Lindkaer-Jensen S; Zacharoulis D; Kostomitsopoulos N; Kasahara N; Nicholls JP; Jiao LR; Pai M; Spalding DR; Mizandari M; Chikovani T; Emara MM; Haoudi A; Tomalia DA; Rossi JJ; Habib NA
    Hepatology; 2014 Jan; 59(1):216-27. PubMed ID: 23929703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C/EBPα Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/β-Catenin Signaling Mediated EMT.
    Huan H; Wen X; Chen X; Wu L; Liu W; Habib NA; Bie P; Xia F
    PLoS One; 2016; 11(4):e0153117. PubMed ID: 27050434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Liver Cancer by C/EBPA saRNA.
    Zhao X; Voutila J; Ghobrial S; Habib NA; Reebye V
    Adv Exp Med Biol; 2017; 983():189-194. PubMed ID: 28639200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms involved in the activation of C/EBPα by small activating RNA in hepatocellular carcinoma.
    Zhao X; Reebye V; Hitchen P; Fan J; Jiang H; Sætrom P; Rossi J; Habib NA; Huang KW
    Oncogene; 2019 May; 38(18):3446-3457. PubMed ID: 30643190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCAAT/enhancer-binding protein α is epigenetically silenced by histone deacetylation in endometriosis and promotes the pathogenesis of endometriosis.
    Kawano Y; Nasu K; Hijiya N; Tsukamoto Y; Amada K; Abe W; Kai K; Moriyama M; Narahara H
    J Clin Endocrinol Metab; 2013 Sep; 98(9):E1474-82. PubMed ID: 23833041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia regulates the expression and localization of CCAAT/enhancer binding protein α by hypoxia inducible factor-1α in bladder transitional carcinoma cells.
    Xue M; Li X; Chen W
    Mol Med Rep; 2015 Aug; 12(2):2121-7. PubMed ID: 25824695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-selective lipopolyplex encapsulated small active RNA hampers colorectal cancer growth in vitro and in orthotopic murine.
    Wang LL; Feng CL; Zheng WS; Huang S; Zhang WX; Wu HN; Zhan Y; Han YX; Wu S; Jiang JD
    Biomaterials; 2017 Oct; 141():13-28. PubMed ID: 28666099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer.
    Voutila J; Reebye V; Roberts TC; Protopapa P; Andrikakou P; Blakey DC; Habib R; Huber H; Saetrom P; Rossi JJ; Habib NA
    Mol Ther; 2017 Dec; 25(12):2705-2714. PubMed ID: 28882451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific up-regulation of p21 by a small active RNA sequence suppresses human colorectal cancer growth.
    Wang LL; Guo HH; Zhan Y; Feng CL; Huang S; Han YX; Zheng WS; Jiang JD
    Oncotarget; 2017 Apr; 8(15):25055-25065. PubMed ID: 28445988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma.
    Tan EH; Hooi SC; Laban M; Wong E; Ponniah S; Wee A; Wang ND
    Cancer Res; 2005 Nov; 65(22):10330-7. PubMed ID: 16288022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth.
    Ren S; Kang MR; Wang J; Huang V; Place RF; Sun Y; Li LC
    Prostate; 2013 Oct; 73(14):1591-601. PubMed ID: 23836514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo".
    Mol Ther; 2016 Dec; 24(12):2131-2132. PubMed ID: 27966559
    [No Abstract]   [Full Text] [Related]  

  • 18. The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.
    Chattopadhyay S; Gong EY; Hwang M; Park E; Lee HJ; Hong CY; Choi HS; Cheong JH; Kwon HB; Lee K
    Mol Endocrinol; 2006 May; 20(5):984-95. PubMed ID: 16455820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades.
    Shi YC; Zhao H; Yin C; Zeng X; Zhang Q; Xu WP; Wei J; Chen F; Xie WF
    Dig Liver Dis; 2013 Oct; 45(10):844-51. PubMed ID: 23816696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.